p53 abnormalities in different subtypes of human sarcomas

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The TP53 tumor suppressor gene plays a critical role in cellular response to DNA damage.
• Dysregulation of p53 is frequently observed in various human cancers, including sarcomas.

Purpose of the Study:

• To investigate the frequency and nature of TP53 alterations at DNA, mRNA, and protein levels across different sarcoma subtypes.
• To determine the extent of TP53 gene involvement in sarcoma tumorigenesis.

Main Methods:

• Analysis of p53 alterations using DNA (loss of heterozygosity), mRNA (transcript levels and integrity), and protein (immunohistochemistry) expression.
• TP53 gene sequencing to identify point mutations in exons 5, 7, and 8.
• Examination of tumor tissue from 39 patients with diverse sarcoma subtypes.

Main Results:

• Loss of heterozygosity in the 17p region was observed in 33-63% of osteosarcomas, malignant fibrous histiocytomas, and leiomyosarcomas.
• Abnormal p53 mRNA levels (elevated, truncated, or absent) and protein overexpression were detected in several tumors.
• TP53 point mutations were identified in seven tumors, often associated with high mRNA and protein levels, suggesting biallelic inactivation.
• Overall, p53 abnormalities were found in approximately 65% of osteosarcomas, malignant fibrous histiocytomas, and leiomyosarcomas, and 30% of other soft tissue tumors.

Conclusions:

• TP53 gene alterations are prevalent in a significant fraction of sarcoma subtypes.
• These findings highlight the crucial role of the TP53 gene in the development of various sarcomas.
• TP53 gene involvement in sarcoma tumorigenesis is more widespread than previously recognized.